Pruritus of Unknown Origin

• CLINICAL_TRIALS research · 2026-04-09
  Clinical Trial Update: Efficacy and Safety of Subcutaneous Dupilumab for the Treatment of Adult Participants With Chronic Pruritus of Unknown Origin (CPUO) (LIBERTY-CPUO-CHIC) [Phase 3]

  A Phase 3 study (LIBERTY-CPUO-CHIC) is evaluating the efficacy and safety of subcutaneous dupilumab for chronic pruritus of unknown origin i…

• CLINICAL_TRIALS research · 2026-02-23
  Clinical Trial Update: Proof of Concept Study to Assess the Pharmacokinetics/Pharmacodynamics of Nemolizumab in Adults With Chronic Pruritus of Unknown Origin (CPUO) [Phase 2]

  Galderma R&D has launched a Phase 2 proof-of-concept study to characterize the pharmacokinetics and pharmacodynamics of nemolizumab in adult…

• CLINICAL_TRIALS trial_result · 2023-07-03
  Clinical Trial Update: Efficacy of Abrocitinib for Reducing Pruritus in Adults With Prurigo Nodularis and Chronic Pruritus of Unknown Origin [Phase 2]

  Phase 2 trial update on abrocitinib showing efficacy in reducing pruritus in adults with prurigo nodularis and chronic pruritus of unknown o…

• CLINICAL_TRIALS trial_result · 2022-07-11
  Clinical Trial Update: A Study of CM310 in Subjects With Chronic Pruritus [Phase 2]

  Phase 2 clinical trial update for CM310 in chronic pruritus of unknown origin.

• CLINICAL_TRIALS trial_result · 2020-09-23
  Clinical Trial Update: Study of the Efficacy, Safety, and Tolerability of Serlopitant for the Treatment of Chronic Pruritus of Unknown Origin [Phase 2]

  Phase 2 trial evaluating serlopitant for chronic pruritus of unknown origin has completed with results posted.

• Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.